Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 8:7:82.
doi: 10.3389/fonc.2017.00082. eCollection 2017.

A Comparison of Pediatric vs. Adult Patients with the Ewing Sarcoma Family of Tumors

Affiliations

A Comparison of Pediatric vs. Adult Patients with the Ewing Sarcoma Family of Tumors

Vivek Verma et al. Front Oncol. .

Abstract

Purpose: This study sought to identify differences in clinical characteristics, outcomes, and treatments between adult and pediatric patients with the Ewing sarcoma family of tumors (ESFT).

Methods: By using the Surveillance, Epidemiology, and End Results database from 1983 to 2013, 1,870 patients were analyzed (n = 976 pediatric, n = 894 adult). Between the two groups, demographic, tumor, and treatment characteristics were collated and compared. The chi-square test determined differences in proportions of the variables between groups. Survival analysis was performed using the Kaplan-Meier method; distributions were compared using the log-rank test. Univariate and multivariate analyses were performed to examine variables correlating with overall survival (OS), the primary endpoint.

Results: Adult patients had a poorer prognosis and were more likely to present with primitive neuroectodermal tumor (PNET) histology, along with distant metastasis and soft tissue primary site. In patients undergoing surgery, radiation therapy (RT) was not associated with higher OS in either children or adults. If no surgery was performed, receipt of RT was associated with higher OS in adults but not children. Adulthood negatively correlated with OS on multivariate analysis when adjusting for potential confounding factors. Other salient factors associated with OS were male gender, metastatic disease, non-extremity bone location, treatment era, and PNET histology. However, when examining the most recent subset (patients treated from 2004 to 2013), RT was associated with improved OS in both pediatrics and adults, which was an independent predictor on multivariate analysis.

Conclusion: Adult patients with ESFT have inferior survival compared to pediatric patients, likely related to earlier clinical detection in the latter.

Keywords: Ewing sarcoma; pediatric oncology; primitive neuroectodermal tumor; radiation therapy; survival.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overall survival in pediatric (blue line) vs. adult (red line) patients.
Figure 2
Figure 2
Overall survival in pediatric and adult patients as stratified by receipt of surgery. Red line denotes pediatric patients undergoing surgery; brown line pediatric patients without surgery; blue line adult patients undergoing surgery; green line adult patients without surgery.
Figure 3
Figure 3
Overall survival in pediatric and adult patients with and without surgery as stratified by receipt of radiotherapy. Green line denotes surgery alone; blue line surgery and radiotherapy; red line radiotherapy alone; brown line neither surgery nor radiotherapy.
Figure 4
Figure 4
Overall survival in pediatric and adult patients without surgery as stratified by receipt of radiotherapy. Brown line denotes pediatric patients without radiotherapy; red line pediatric patients undergoing radiotherapy; blue line adult patients undergoing radiotherapy; green line adult patients without radiotherapy.
Figure 5
Figure 5
In the 2004–2013 cohort, overall survival in pediatric and adult patients as stratified by receipt of radiotherapy. Brown line denotes pediatric patients without radiotherapy; red line pediatric patients undergoing radiotherapy; blue line adult patients undergoing radiotherapy; green line adult patients without radiotherapy.

Similar articles

Cited by

References

    1. Esiashvili N, Goodman M, Marcus RB, Jr. Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: surveillance, epidemiology, and end results data. J Pediatr Hematol Oncol (2008) 30:425–30.10.1097/MPH.0b013e31816e22f3 - DOI - PubMed
    1. Verrill MW, Judson IR, Harmer CL, Fisher C, Thomas JM, Wiltshaw E. Ewing’s sarcoma and primitive neuroectodermal tumor in adults: are they different from Ewing’s sarcoma and primitive neuroectodermal tumor in children? J Clin Oncol (1997) 17:2611–21.10.1200/JCO.1997.15.7.2611 - DOI - PubMed
    1. Fizazi K, Dohollou N, Blay JY, Guérin S, Le Cesne A, André F, et al. Ewing’s family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients. J Clin Oncol (1998) 16:3736–43.10.1200/JCO.1998.16.12.3736 - DOI - PubMed
    1. Cotterill SJ, Ahrens S, Paulussen M, Jürgens HF, Voûte PA, Gadner H, et al. Prognostic factors in Ewing’s tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing’s Sarcoma Study Group. J Clin Oncol (2000) 18:3108–14.10.1200/JCO.2000.18.17.3108 - DOI - PubMed
    1. Oberlin O, Deley MC, Bui BN, Gentet JC, Philip T, Terrier P, et al. Prognostic factors in localized Ewing’s tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study). Br J Cancer (2001) 85:1646–54.10.1054/bjoc.2001.2150 - DOI - PMC - PubMed

LinkOut - more resources